Presently, Alzheimer's Disease is incurable. However, the U.S. Food and Drug Administration (FDA) has approved six (6) prescription medications for treating some of the memory-loss symptoms associated with cognitive impairment and dementia. These pharmaceuticals fall into three (3) broad categories.
Firstly, there are acetylcholinesterase inhibitors (AChEI). These are designed to boost the brain's levels of the neurotransmitter acetylcholine by hindering the body's ability to break it down. These drugs include donepezil (Aricept), galantamine (Razadyne/Reminyl), rivastigmine (Exelon), and the now-obsolete tacrine (Cognex).
For a more in-depth explanation of how this first sort of drug works, see my video:
Secondly, come the NMDA-receptor antagonists (NMDARA). These have to do with the funciton of the N-methyl-D-aspartate receptor and the neurotransmitter glutamate. At the present time, the main offering, here, is memantine (Namenda).
Thirdly, are composite medications that combine the actions of the first two categories. To put it differently, and as of this writing, researchers have put donepezil together with memantine (to create Namzaric).
None of these interventions is curative. They do not reverse Alzheimer's. They may, however, be able to slow down a person's cognitive decline. However, these drugs may have side effects.
Disclaimer: I am not a doctor, pharmacist, or healthcare / medical practitioner of any kind. This video is for general informational or entertainment purposes only. Nothing herein should be construed as medical or pharmaceutical advice. For personalized recommendations and prescriptions, you need to consult a licensed physician in your area.
For further reading, please visit:
AlzheimersProof.com
Pinterest.com/alzheimersproof
0 Comments